References | CAYSTON® (aztreonam for inhalation solution)

Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91-100.
Cystic Fibrosis Foundation. 2019 Patient Registry Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation; 2019. Accessed January 12, 2022. https://www.cff.org/sites/default/files/2021-10/2019-Patient-Registry-Annual-Data-Report.pdf
Cystic Fibrosis Foundation. CFF.org. Pseudomonas. Accessed September 30, 2022. https://www.cff.org/managing-cf/pseudomonas
US National Library of Medicine website. Cystic Fibrosis. Updated August 18, 2020. Accessed September 30, 2022. https://medlineplus.gov/genetics/condition/cystic-fibrosis/
Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680-689.
Pritt B, O’Brien L, Winn W. Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol. 2007;128(1): 32-34.
Cystic Fibrosis Foundation. CFF.org. Basics of lung care. Accessed September 30, 2022. https://www.cff.org/basics-lung-care
Cunningham JC, Taussig LM. Respiratory System. In: An Introduction to Cystic Fibrosis: For Patients and Their Families. 6th ed. Cystic Fibrosis Foundation; 2013:41-58.
Starner TD, McCray PB. Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity to Eradicate Bacteria. Ann Intern Med. 2005;143(11):816-822.
Li Z, Kosorok MR, Farrell PM, et al. Longitudinal Development of Mucoid Pseudomonas aeruginosa Infection and Lung Disease Progression in Children With Cystic Fibrosis. JAMA. 2005; 293(5):581-588.
Kriengkauykiat J, Benitez D, Beringer P. Bacteria and Antibiotic Resistance in People With Cystic Fibrosis. Cystic Fibrosis Foundation; University of Southern California. Accessed January 12, 2022. https://intmed.vcu.edu/media/intmed-dev/cf/cf-documents/cf-documents/bacteria_antibiotic_resistance.pdf
Retsch-Bogart GZ, Quittner AL, Gibson RL, et al. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest. 2009;135(5):1223-1232.
Assael BM, Pressler T, Bilton D, et al. Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial. J Cyst Fibros. 2013;12(2):130-140.
Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2(1):29-34.
Cystic Fibrosis Foundation. CFF.org. CF care center visits. Accessed September 30, 2022. https://www.cff.org/managing-cf/cf-care-center-visits
Cystic Fibrosis Foundation. CFF.org. Maintaining healthy weight with Cystic Fibrosis. Accessed September 30, 2022. https://www.cff.org/sites/default/files/2021-10/Maintaining-Healthy-Weight-With-Cystic-Fibrosis.pdf
New South Wales Ministry of Health. Sputum induction guidelines. NSW Government Health. Accessed September 23, 2021. https://www.health.nsw.gov.au/Infectious/tuberculosis/Pages/tb-sputum-induction-guidelines.aspx
Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162(3):530-535.

IMPORTANT SAFETY INFORMATION

Who should not take CAYSTON?

Do not take CAYSTON if you are allergic to aztreonam, or any of the ingredients in CAYSTON.

What should I tell my healthcare provider before taking CAYSTON?

Tell your healthcare provider about all of your medical conditions, including if you are allergic to any antibiotics; if you are pregnant or plan to become pregnant, as it is not known if CAYSTON can harm your unborn baby; if you are breastfeeding or plan to breastfeed, as CAYSTON can pass into your breastmilk. Talk with your healthcare provider about the best way to feed your baby while you are taking CAYSTON.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.